Bayer Shares Surge as U.S. Supreme Court Reviews Roundup Case

Bayer’s shares experienced a notable surge following a recent decision by the U.S. Supreme Court. The court has agreed to review Bayer’s appeal regarding claims associated with its herbicide, Roundup.

Bayer’s Stock Performance

On Monday, Bayer’s stock rose by 6.95% during trading hours. The shares increased significantly, reaching a price of 44.42 euros, up by about 7% in European markets.

Background on Roundup Litigation

The case focuses on allegations that Roundup, Bayer’s flagship weedkiller, causes cancer. Bayer has consistently denied these allegations but faces ongoing litigation related to the product.

Market Reaction

• Bayer’s shares rose 6.95% on a Monday.
• In European trading, shares reached 44.42 euros.
• The increase amounted to roughly 7% during the session.

The Supreme Court’s decision to review the case brings renewed attention to Bayer’s legal challenges. Investors remain optimistic about the potential outcomes of this landmark litigation.